Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant for relapse prevention in detoxified cocaine-dependent adults
NL-OMON20293Not yet recruiting
- Sponsor
- Prof. dr. Wim Van den Brink dr. Jan Booij dr. Michelle Miller drs. Cleo Crunelle
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cocaine use disorder (CUD) comparing Rimonabant with Placebo (2 arms). Primary endpoints: Change in striatal dopamine D2 receptor availability, Cocaine craving and impulsivity and 1 more. Planned start Sep 2008; status: not yet recruiting.
02
Drugs
rimonabant
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NL-OMON20293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20293.